Businesses

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

April 1, 2026

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

March 30, 2026

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

February 23, 2026

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

February 20, 2026